Animals: Innovation
in Animal Health
Combat Diseases
ASPIRATION
Combat diseases that pose the greatest risk to animals and humans
Leverage the Zoetis Center for Transboundary and Emerging Diseases to develop vaccines for high-impact emerging diseases globally
TARGET
Invest in R&D for emerging infectious diseases
2023 PROGRESS
Expanded our research capabilities for transboundary animal diseases and emerging infectious diseases.
TARGET
Provide our innovative vaccines to all relevant markets via tenders or other go-to-market pathways
2023 PROGRESS
Supported endangered species protection programs.
Collaborated to support One Health initiatives.
Emerging and Infectious Diseases
Through our Center for Transboundary and Emerging Diseases (CTED), we conduct veterinary biosurveillance and develop or support vaccines for high-impact TADs and EIDs around the world, including Avian Influenza, Porcine Epidemic Diarrhea Virus, Schmallenberg Virus, Hendra Virus, Bluetongue Virus, Lumpy Skin Disease, Canine Influenza, Rabies, Lyme disease, West Nile Virus, Avian Pneumovirus and SARS-CoV-2.
Our scientists also organize our response to outbreaks of infectious diseases worldwide, mobilizing resources from across the company and working in close collaboration with leaders from government and health organizations, as well as veterinary and livestock agricultural communities to identify infectious disease threats early and develop solutions to help rapidly control them.
Download our 2023 Sustainability Report
Advancing sustainability in animal health for a better future.
Learn more
Up Next: Planet